U.S. Medical Equipment Stock News

Syndax Pharmaceuticals (SNDX) is back in focus after highlighting 12 new Revuforj abstracts ahead of the European Hematology Association 2026 Congress, drawing attention to extensive clinical and real-world data across acute leukemia settings. See our latest analysis for Syndax Pharmaceuticals. The recent Revuforj data spotlight comes as Syndax’s share price sits at US$20.13, with a year to date share price return down 5.49% but a 1 year total shareholder return of 89.01%, suggesting longer...

Core & Main (CNM) has been drawing fresh attention as it reports wider free cash flow margins, continues share repurchases, and steps up visibility at water industry conferences in Kentucky, North Carolina, and New Jersey this May. See our latest analysis for Core & Main. At a share price of US$47.12, Core & Main has seen a 1-day share price return of 4.73%, although the share price is down 11.78% year to date and the 1-year total shareholder return is down 10.57%. The 3-year total...

Packaging Corporation of America (PKG) is back on investors’ radar after its recent share price move, with the stock now around $213.21 and showing mixed returns across the past week, month, and past 3 months. See our latest analysis for Packaging Corporation of America. The recent 1-day share price gain of 4.94% contrasts with a 90 day share price return that is down 10.77%, while the 1 year total shareholder return of 14.50% points to momentum that has been building over a longer...

In the past few days, Tsakos Energy Navigation reported fourth-quarter 2025 results that materially exceeded earnings and revenue expectations, underscoring strong operational performance in its energy transportation business. This outperformance against analyst forecasts highlights the company’s ability to leverage its fleet and contracts more efficiently than the market had anticipated. We’ll now examine how this earnings beat, and what it suggests about Tsakos Energy Navigation’s...

Vita Coco Company stock snapshot Vita Coco Company (COCO) has drawn attention after a strong recent run, with the stock up 64.1% over the past month and 50.5% over the past 3 months. This performance is inviting closer scrutiny of its fundamentals. See our latest analysis for Vita Coco Company. At a share price of $77.88, Vita Coco’s recent surge reflects building momentum, with a 64.1% 1 month share price return and a 111.4% 1 year total shareholder return hinting at shifting growth and risk...

In May 2026, Vontier Corporation’s board increased its share repurchase authorization to US$1.00 billion and affirmed a quarterly dividend of US$0.025 per share payable on June 25, 2026, following an ex-dividend and record date of June 4, 2026. This larger buyback pool, alongside ongoing dividends, highlights management’s emphasis on capital returns at a time when investors are reassessing Vontier’s operating trends and cash allocation priorities. We’ll now examine how Vontier’s expanded...

Polestar Automotive Holding UK PLC recently outlined its ongoing manufacturing diversification, future model pipeline including the Polestar 4 variant and Polestar 7 compact SUV, and its climate targets around halving per-vehicle emissions by 2030 and reaching climate neutrality by 2040, while also presenting at Deutsche Bank’s Global Autos, Mobility & Robotics Conference in New York and holding its 2026 AGM in London in June. An interesting angle for investors is how Polestar’s combination...

In May 2026, Nektar Therapeutics announced a US$150 million at-the-market follow-on equity offering and a leadership transition, with seasoned FLG Partners executive Linda Rubinstein replacing retiring interim CFO Sandra Gardiner. The appointment of Rubinstein, who has helped raise more than US$5 billion and overseen over US$1 billion in M&A value, highlights Nektar’s focus on experienced capital markets leadership as it continues to fund its pipeline. Next, we’ll examine how this...

In early May 2026, McKesson reported fourth-quarter sales of US$96.30 billion and net income of US$1.68 billion, with full-year sales reaching US$403.43 billion and net income of US$4.76 billion, alongside robust earnings per share growth from continuing operations. At the same time, McKesson completed a very large share repurchase program totaling 66.50 million shares for US$21.13 billion, a move that aligns with institutional investors’ focus on its resilient pharmaceutical distribution...

NVR, Inc. in early May 2026 authorized a new share repurchase program of up to US$750,000,000 with no expiration, alongside routine equity option grants to directors and senior executives tied in part to future return on capital performance. The buyback authorization came shortly after shareholders declined to approve a proposal on greenhouse gas emissions disclosure, underscoring management’s current priorities around capital allocation and governance. We’ll now examine how NVR’s sizeable,...

Vishay Precision Group, Inc. ( NYSE:VPG ) just reported some strong earnings, and the market reacted accordingly with a...

Investors may be wondering whether Alcoa, at around US$64 a share, still offers value or if most of the opportunity has already been priced in. The stock is up 13.4% year to date and 128.6% over the past year, even though it has fallen 6.3% over the last week and 3.6% over the past month. These moves sit against a backdrop of ongoing attention on metals and mining companies, with investors weighing factors such as commodity demand, input costs and capital allocation decisions. Short term...

Earlier this month, Coursera’s board approved an open-ended share repurchase program of up to US$500,000,000, funded from existing cash and cash flow, following its completed merger with Udemy and recent increases in authorized common stock. This move, alongside fresh board appointments from Udemy and a new shelf registration for ESOP-related shares, signals a meaningful shift in how Coursera balances capital returns, governance, and employee ownership after the combination. Next, we’ll...

DexCom (NasdaqGS:DXCM) has launched Dexcom Flex, a continuous glucose monitoring system for adults with Type 2 diabetes in Germany. The system is aimed at patients who are not on intensive insulin therapy, including those using basal insulin, oral medications or GLP-1 receptor agonists. This rollout extends DexCom's CGM offering to a broader segment of the Type 2 diabetes population that historically had limited CGM access. DexCom focuses on continuous glucose monitoring technology for...

NorthStar Clean Energy's Aviator Wind project, a 525 MW single site wind facility, has appointed Consolidated Asset Management Services (CAMS) as its new asset management partner. CAMS will oversee operations, maintenance, and compliance for the Aviator Wind site, one of the largest single site wind projects in the U.S. The project is owned by NorthStar Clean Energy, a subsidiary of CMS Energy (NYSE:CMS). The change in asset manager represents a material operational shift for the...

Clearway Energy, Inc. recently reported mixed first-quarter 2026 results, with sales rising to US$354 million but a net loss of US$163 million, reaffirmed its full-year cash available for distribution guidance and long-term targets, and outlined multi-year investment plans in wind repowering, storage and acquisitions. Ahead of a June 2026 leadership change in the General Counsel role, the company is emphasizing continuity in governance as it pursues growth tied to rising power demand,...

Plains All American Pipeline, L.P. has reported past first-quarter 2026 results, with revenue rising to US$12,470 million from US$11,477 million a year earlier, while net income fell to US$152 million from US$443 million. Although basic earnings per share from continuing operations were broadly steady, overall basic earnings per share dropped to US$0.14 from US$0.49, highlighting pressure on profitability despite higher revenue. Next, we will examine how higher revenue but weaker net income...

Earlier this month, Sotera Health completed a follow-on equity offering of 31,838,253 common shares at US$15.27 each, raising about US$486.17 million at a small discount to the offer price. This sizeable capital raise materially increases Sotera Health’s funding flexibility, potentially affecting how investors assess its balance sheet strength and future investment capacity. We’ll now examine how this sizable follow-on equity raise could reshape Sotera Health’s investment narrative and...

Monarch Casino & Resort (MCRI) is back in focus after a significant earnings beat and recent room renovations in Reno, a combination that helped push the stock to an all time high near US$120. See our latest analysis for Monarch Casino & Resort. That earnings surprise and the Reno refresh sit alongside a strong 30 day share price return of 17.18% and a 1 year total shareholder return of 45.24%. Together, these point to momentum building around the Monarch Casino & Resort story and changing...

Carter's, Inc. ( NYSE:CRI ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business day...

Wondering if Urban Outfitters at US$71.67 is priced for opportunity or caution? This article walks through what that share price could mean for you as an investor. The stock is up 7.9% over the past week, while it is down 5.9% over the past month, down 4.9% year to date, and has returned 20.3% over the past year, 128.6% over three years, and 86.3% over five years. Recent coverage around Urban Outfitters has focused on its position within Specialty Retail and how investors are reacting to its...

Earlier this week, FMC Corporation completed a fixed-income offering of US$750 million in senior secured notes due 2031, issued under Regulation S and Rule 144A with attached guarantees. This substantial bond raise strengthens FMC’s financial toolkit, potentially giving the company more flexibility to fund operations, address debt, or support future growth initiatives. Next, we’ll examine how FMC’s US$750 million senior secured notes could influence its investment narrative and balance-sheet...

With no single headline event driving attention to Glacier Bancorp (GBCI) today, the focus for investors is on the bank’s recent share performance and current valuation signals in a shifting regional banking backdrop. See our latest analysis for Glacier Bancorp. Glacier Bancorp’s recent 1-day share price return of 2.39% comes after a softer 30-day share price return, while the 1-year total shareholder return of 20.75% and 3-year total shareholder return of 79.18% point to longer term momentum...

Erasca (NasdaqGS:ERAS) entered a collaboration with Merck to study ERAS-0015 in combination with KEYTRUDA in RAS mutant solid tumors. The companies agreed a new clinical trial arrangement that will evaluate the combination regimen in late-stage settings. Erasca focuses on therapies that target the RAS pathway, an area of high interest across oncology research. KEYTRUDA is a widely used immuno-oncology therapy, so pairing it with ERAS-0015 places the company in a clinically and commercially...